BibTex RIS Cite

Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması

Year 2008, Volume: 39 Issue: 2, 56 - 62, 20.07.2014

Nuren Beşe Kimia Çepni İsmail Çepni Basri Günhan Ayşe Koca Songül Karaçam Didem Öksüz

Keywords

Hodgkin hastalığı fetal doz radyoterapi

References

  • Kal HB, Struikmans H. Radiotherapy during pregnan- cy: fact and fiction. Lancet Oncol 2005; 6: 328-333.
  • Tewari KS. Cancer in pregnancy. In: DiSaia PJ, Creasman WT, eds. Clinical Gynecologic Oncology. 7th ed. Mosby: Elsevier; 2007: 468-531.
  • Pavlidis NA. Coexistence of pregnancy and malignan- cy. Oncologist 2002; 7: 279- 287.
  • Hall EJ, Giaccia AJ. Effects of radiation on the embryo and fetus. Radiobiology for the radiologist. 6th ed. Philadelphia: Lippincott; 2006; 168-180.
  • Pereg D, Koren G, Lishner M. The treatment of Hodgkin’s and non-Hodgkin’s lymhoma in pregnancy. Haematologica 2007; 92: 1230-1237.
  • Hoppe RT. Hodgkin’s disease. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, eds. Principles and practice of Radiation Oncology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2004: 2043-2063.
  • Diehl V, Brillant C, Engert A, et al. HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG). J Clin Oncol (Meeting Abstracts) 2005; 23: 6506.
  • Woo SY, Fuller LM, Cundiff JH, et al. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin’s disease. Int J Radiat.Oncol Biol Phys. 1992; 23: 407- 412.
  • Nuyttens JJ, Prado KL, Jenrette JM, Williams TE. Fetal dose during radiotherapy: clinical implementation and review of the literature. Cancer Radiother 2002; 6: 352-357.
  • Zucali R, Marchesini R, De Palo G. Abdominal dosimetry for supradiaphragmatic irradiation of Hodgkin’s disease in pregnancy: experimental data and clinical consideration. Tumori 1981; 67: 203-208.
  • Nisce LZ, Tome MA, He S, et al. Management of coex- isting Hodgkin’s disease and pregnancy. Am J Clin Oncol 1986; 9: 146-151.
  • Mazonakis M, Varveris H, Fasoulaki M, Damilakis J. Radiotherapy of Hodgkin’s disease in early pregnancy: embryo dose measurements. Radiother Oncol 2003; 66: 333-339.
  • Cygler J, Ding GX, Kendal W, Cross P. Fetal dose for a patient undergoing mantle field irradiation for Hodgkin’s disease. Med Dosim 1997; 22: 135-137.
  • International Commission on Radiological Protection. Pregnancy and medical radiation. Ann ICRP 2000; 30: 1-43.
  • International Commission on Radiological Protection. Biological effects after prenatal irradiation(embryo and fetus). Ann ICRP 2003; 33: 205-206.
  • Hammer-Jacobsen E. Therapeutic abortion on account X-ray examination during pregnancy. Dan Med Bull 1959; 6: 113-122.
  • Wagner LK, Lester RG, Saldana LR. Exposure of the pregnant patient to diagnostic radiations. 2nd ed. Madison, Wisconsin: Medical Physics Publishing; 1997.
  • Stovall M, Blackwell CR, Cundiff J, Novack DH, et al. Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Committee Task Group no: 36. Med Phys 1995; 22: 63-82.
  • Lishner M, Zemlickis D, Degendorfer P, et al. Maternal and fetal outcome following Hodgkin’s disease in pregnancy. Br J Cancer 1992; 65: 114-117.
  • Sneed PK, Albright NW, War WM, et al. Fetal dose esti- mates for radiotherapy of brain tumors during pregnan- cy. Int J Radiat Oncol Biol Phys 1995; 32: 823-830.
  • Antypas C, Sandilos P, Kouvaris J, et al. Fetal dose evaluation during breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 1998; 40: 995-999.
  • Greskovich JF, Macklis RM. Radiation therapy in preg- nancy: risk calculation and risk minimization. Seminars in Oncology 2000; 27: 633-645.
  • Ioachim HL. Non-Hodgkin’s lymphoma in pregnancy: three cases and review of the literature. Arch Pathol Lab Med 1985; 109: 803-809.

Year 2008, Volume: 39 Issue: 2, 56 - 62, 20.07.2014

Nuren Beşe Kimia Çepni İsmail Çepni Basri Günhan Ayşe Koca Songül Karaçam Didem Öksüz

References

  • Kal HB, Struikmans H. Radiotherapy during pregnan- cy: fact and fiction. Lancet Oncol 2005; 6: 328-333.
  • Tewari KS. Cancer in pregnancy. In: DiSaia PJ, Creasman WT, eds. Clinical Gynecologic Oncology. 7th ed. Mosby: Elsevier; 2007: 468-531.
  • Pavlidis NA. Coexistence of pregnancy and malignan- cy. Oncologist 2002; 7: 279- 287.
  • Hall EJ, Giaccia AJ. Effects of radiation on the embryo and fetus. Radiobiology for the radiologist. 6th ed. Philadelphia: Lippincott; 2006; 168-180.
  • Pereg D, Koren G, Lishner M. The treatment of Hodgkin’s and non-Hodgkin’s lymhoma in pregnancy. Haematologica 2007; 92: 1230-1237.
  • Hoppe RT. Hodgkin’s disease. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, eds. Principles and practice of Radiation Oncology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2004: 2043-2063.
  • Diehl V, Brillant C, Engert A, et al. HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG). J Clin Oncol (Meeting Abstracts) 2005; 23: 6506.
  • Woo SY, Fuller LM, Cundiff JH, et al. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin’s disease. Int J Radiat.Oncol Biol Phys. 1992; 23: 407- 412.
  • Nuyttens JJ, Prado KL, Jenrette JM, Williams TE. Fetal dose during radiotherapy: clinical implementation and review of the literature. Cancer Radiother 2002; 6: 352-357.
  • Zucali R, Marchesini R, De Palo G. Abdominal dosimetry for supradiaphragmatic irradiation of Hodgkin’s disease in pregnancy: experimental data and clinical consideration. Tumori 1981; 67: 203-208.
  • Nisce LZ, Tome MA, He S, et al. Management of coex- isting Hodgkin’s disease and pregnancy. Am J Clin Oncol 1986; 9: 146-151.
  • Mazonakis M, Varveris H, Fasoulaki M, Damilakis J. Radiotherapy of Hodgkin’s disease in early pregnancy: embryo dose measurements. Radiother Oncol 2003; 66: 333-339.
  • Cygler J, Ding GX, Kendal W, Cross P. Fetal dose for a patient undergoing mantle field irradiation for Hodgkin’s disease. Med Dosim 1997; 22: 135-137.
  • International Commission on Radiological Protection. Pregnancy and medical radiation. Ann ICRP 2000; 30: 1-43.
  • International Commission on Radiological Protection. Biological effects after prenatal irradiation(embryo and fetus). Ann ICRP 2003; 33: 205-206.
  • Hammer-Jacobsen E. Therapeutic abortion on account X-ray examination during pregnancy. Dan Med Bull 1959; 6: 113-122.
  • Wagner LK, Lester RG, Saldana LR. Exposure of the pregnant patient to diagnostic radiations. 2nd ed. Madison, Wisconsin: Medical Physics Publishing; 1997.
  • Stovall M, Blackwell CR, Cundiff J, Novack DH, et al. Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Committee Task Group no: 36. Med Phys 1995; 22: 63-82.
  • Lishner M, Zemlickis D, Degendorfer P, et al. Maternal and fetal outcome following Hodgkin’s disease in pregnancy. Br J Cancer 1992; 65: 114-117.
  • Sneed PK, Albright NW, War WM, et al. Fetal dose esti- mates for radiotherapy of brain tumors during pregnan- cy. Int J Radiat Oncol Biol Phys 1995; 32: 823-830.
  • Antypas C, Sandilos P, Kouvaris J, et al. Fetal dose evaluation during breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 1998; 40: 995-999.
  • Greskovich JF, Macklis RM. Radiation therapy in preg- nancy: risk calculation and risk minimization. Seminars in Oncology 2000; 27: 633-645.
  • Ioachim HL. Non-Hodgkin’s lymphoma in pregnancy: three cases and review of the literature. Arch Pathol Lab Med 1985; 109: 803-809.
There are 23 citations in total.

Details

Primary Language Turkish
Journal Section Araştırmalar
Authors

Nuren Beşe This is me

Kimia Çepni This is me

İsmail Çepni This is me

Basri Günhan This is me

Ayşe Koca This is me

Songül Karaçam This is me

Didem Öksüz This is me

Publication Date July 20, 2014
Published in Issue Year 2008 Volume: 39 Issue: 2

Cite

APA Beşe, N., Çepni, K., Çepni, İ., Günhan, B., et al. (2014). Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması. Cerrahpaşa Tıp Dergisi, 39(2), 56-62.
AMA Beşe N, Çepni K, Çepni İ, Günhan B, Koca A, Karaçam S, Öksüz D. Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması. Cerrahpaşa Tıp Dergisi. July 2014;39(2):56-62.
Chicago Beşe, Nuren, Kimia Çepni, İsmail Çepni, Basri Günhan, Ayşe Koca, Songül Karaçam, and Didem Öksüz. “Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması”. Cerrahpaşa Tıp Dergisi 39, no. 2 (July 2014): 56-62.
EndNote Beşe N, Çepni K, Çepni İ, Günhan B, Koca A, Karaçam S, Öksüz D (July 1, 2014) Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması. Cerrahpaşa Tıp Dergisi 39 2 56–62.
IEEE N. Beşe, “Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması”, Cerrahpaşa Tıp Dergisi, vol. 39, no. 2, pp. 56–62, 2014.
ISNAD Beşe, Nuren et al. “Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması”. Cerrahpaşa Tıp Dergisi 39/2 (July 2014), 56-62.
JAMA Beşe N, Çepni K, Çepni İ, Günhan B, Koca A, Karaçam S, Öksüz D. Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması. Cerrahpaşa Tıp Dergisi. 2014;39:56–62.
MLA Beşe, Nuren et al. “Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması”. Cerrahpaşa Tıp Dergisi, vol. 39, no. 2, 2014, pp. 56-62.
Vancouver Beşe N, Çepni K, Çepni İ, Günhan B, Koca A, Karaçam S, Öksüz D. Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması. Cerrahpaşa Tıp Dergisi. 2014;39(2):56-62.